Це відео не доступне.
Перепрошуємо.
Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21
Вставка
- Опубліковано 6 сер 2024
- Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., discuss preliminary reports of Guillain-Barré Syndrome (GBS) following Janssen #COVID19 vaccination.